Elvn-001, a Next Generation ATP-Competitive ABL1 Tyrosine Kinase Inhibitor for the Treatment of Chronic Myeloid Leukemia
| Autor: | Gross, Stefan D *, Eide, Christopher A. *, Burkard, Michael R *, Reister Schultz, Anna *, Aujay, Monette A *, Kintz, Samuel *, Druker, Brian J., Lyssikatos, Joseph P * |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:3095-3096 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|